Medical registries

被引:18
作者
Bestehorn, K [1 ]
机构
[1] Tech Univ Dresden, Inst Klin Pharmakol, D-8027 Dresden, Germany
关键词
registries; health care research; quality assurance;
D O I
10.1007/s00063-005-1098-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The target-oriented distribution of increasingly limited health care resources requires knowledge about the benefit of established measures and the health care situation. This is the purpose of health care research. In this overview, the role of registries in regard to health care research is described. Medical Registries: Registries, a collection of standardized medical and socioeconomic data, investigate systematically and comprehensively for a certain purpose and are therefore appropriate to describe the actual treatment in regard to undersupply, excess supply, and missupply. One example would be the use of statins in risk profile-oriented primary and secondary prevention of cardiovascular events. Furthermore, positive experience from registries is available, as in the case of quality assurance management. In registries for myocardial infarction. like MIR, MITR-A and ACOS, feedback about therapy compared with guidelines along with the request to explain deviation from guidelines resulted in a significant reduction of hospital mortality. The methodological necessities and limitations of the informational value are pointed out. Conclusion: Registries are able to contribute substantially to health care research.
引用
收藏
页码:722 / 728
页数:7
相关论文
共 37 条
[1]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[2]  
BALLACH B, 2000, BUNDESGESUNDHEITSBLA, V43, P424
[3]  
BENECKE H, 2004, J PUBLIC HLTH, V12, P78
[4]  
BESTEHORN KP, 2004, ADEQUATE USE STATINS
[5]  
BESTEHORN KP, 2003, OSTEOLOGIE S1, V12
[6]  
FETSCH T, 2004, GESUNDHEITSFORSCH GE, V47, P563
[7]  
FLOREY CDV, 2001, DICT EPIDEMIOLOGY
[8]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[9]   Factors associated with differences in antihypertensive drug treatment:: results from the MONICA Augsburg Population Surveys 1989/90 and 1994/95 [J].
Gasse, C ;
Hense, HW ;
Stieber, J ;
Döring, A ;
Liese, AD ;
Heller, G ;
Keil, U .
SOZIAL-UND PRAVENTIVMEDIZIN, 2002, 47 (02) :128-139
[10]   Empfehlungen zur umfassenden Risikoverringerung für Patienten mit koronarer Herzerkrankung, Gefäßerkrankungen und Diabetes Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung Bearbeitet im Auftrag der Kommission Klinische Kardiologie durch die Projektgruppe PräventionHerausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung Bearbeitet im Auftrag der Kommission Klinische Kardiologie durch die Projektgruppe Prävention [J].
H. Gohlke ;
W. Kübler ;
P. Mathes ;
T. Meinertz ;
G. Schuler ;
D. B. Gysan ;
G. Sauer .
Zeitschrift für Kardiologie, 2001, 90 (2) :148-149